ABVC
Price
$3.23
Change
+$0.33 (+11.38%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
68.27M
CORT
Price
$83.84
Change
+$0.52 (+0.62%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
8.78B
35 days until earnings call
Interact to see
Advertisement

ABVC vs CORT

Header iconABVC vs CORT Comparison
Open Charts ABVC vs CORTBanner chart's image
ABVC BioPharma
Price$3.23
Change+$0.33 (+11.38%)
Volume$1.1K
Capitalization68.27M
Corcept Therapeutics
Price$83.84
Change+$0.52 (+0.62%)
Volume$85.16K
Capitalization8.78B
ABVC vs CORT Comparison Chart in %
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. CORT commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Buy and CORT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (ABVC: $2.90 vs. CORT: $83.32)
Brand notoriety: ABVC and CORT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 33% vs. CORT: 112%
Market capitalization -- ABVC: $68.27M vs. CORT: $8.78B
ABVC [@Biotechnology] is valued at $68.27M. CORT’s [@Biotechnology] market capitalization is $8.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileCORT’s FA Score has 1 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • CORT’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than ABVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 3 TA indicator(s) are bullish while CORT’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 3 bullish, 5 bearish.
  • CORT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CORT is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а +2.11% price change this week, while CORT (@Biotechnology) price change was +16.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

CORT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($8.78B) has a higher market cap than ABVC($68.3M). ABVC YTD gains are higher at: 391.525 vs. CORT (65.350). CORT has higher annual earnings (EBITDA): 104M vs. ABVC (-3.57M). CORT has more cash in the bank: 342M vs. ABVC (453K). ABVC has less debt than CORT: ABVC (1.59M) vs CORT (6.61M). CORT has higher revenues than ABVC: CORT (716M) vs ABVC (391K).
ABVCCORTABVC / CORT
Capitalization68.3M8.78B1%
EBITDA-3.57M104M-3%
Gain YTD391.52565.350599%
P/E RatioN/A74.39-
Revenue391K716M0%
Total Cash453K342M0%
Total Debt1.59M6.61M24%
FUNDAMENTALS RATINGS
ABVC vs CORT: Fundamental Ratings
ABVC
CORT
OUTLOOK RATING
1..100
719
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
10035
SMR RATING
1..100
9843
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (63) in the null industry is in the same range as CORT (83) in the Pharmaceuticals Other industry. This means that ABVC’s stock grew similarly to CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for ABVC (100) in the null industry. This means that CORT’s stock grew somewhat faster than ABVC’s over the last 12 months.

CORT's SMR Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for ABVC (98) in the null industry. This means that CORT’s stock grew somewhat faster than ABVC’s over the last 12 months.

ABVC's Price Growth Rating (35) in the null industry is in the same range as CORT (41) in the Pharmaceuticals Other industry. This means that ABVC’s stock grew similarly to CORT’s over the last 12 months.

CORT's P/E Growth Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for ABVC (100) in the null industry. This means that CORT’s stock grew significantly faster than ABVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCCORT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 10 days ago
66%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URE64.550.89
+1.40%
ProShares Ultra Real Estate
MANA2.15N/A
+0.19%
Grayscale Decentraland Trust (MANA)
FCFY27.32N/A
N/A
First Trust S&P 500 Div Fr CA Flw ETF
GAL49.35-0.09
-0.19%
SPDR® SSgA Global Allocation ETF
VTWG236.80-1.05
-0.44%
Vanguard Russell 2000 Growth ETF

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with MRSN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
+1.05%
MRSN - ABVC
33%
Loosely correlated
-0.14%
CORT - ABVC
28%
Poorly correlated
+4.15%
TENX - ABVC
23%
Poorly correlated
+1.56%
PROK - ABVC
23%
Poorly correlated
-2.49%
SONN - ABVC
23%
Poorly correlated
+4.20%
More

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
+4.15%
VTVT - CORT
48%
Loosely correlated
-0.75%
DNLI - CORT
40%
Loosely correlated
-2.03%
TENX - CORT
38%
Loosely correlated
+1.56%
ARCT - CORT
38%
Loosely correlated
-3.66%
HNSBF - CORT
38%
Loosely correlated
N/A
More